Manzo Pharmaceuticals Inc. (MNZO)

[Scumbag Fraudsters]

Caveat Emptor securities will be limited to liquidation-only by May 25


Caveat Emptor securities come with very high potential risk for investors. They can be volatile and illiquid (not easily converted to cash), and they can place a significant burden on investors in terms of investment research and due diligence. The OTC Markets Group will designate a security as Caveat Emptor if they become aware of one or more of the following risk factors:

• Misleading or manipulative stock promotion
• Fraud investigation or criminal activity related to the company or to insiders
• Regulatory trading suspensions or halts
• Disruptive or undisclosed corporate actions
• Other reasons related to the public interest


What securities are affected by this change?
You can find a list of impacted securities—subject to change—at schwab.com/caveatemptor.


MANZO PHARMACEUTICAL is on the list.